Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2 | CD24 | CD73 | Trimer | CD19 | PD-1
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > COVID-19 R&D
COVID-19 R&D
News
Exhibitions
Promotion
The importance of N protein variants in antibody test and drug design
2021/04/14     Read: 516
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
Have you noticed that NTD could be a pivotal player during infection?
2021/03/12     Read: 990
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
One jab and you’re done! CanSino and Johnson & Johnson adenovirus vaccines receive regulatory approval.
2021/03/08     Read: 1561
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
A year later: What we know about SARS-CoV-2 infectivity and growing concerns of emerging variants
It has been a year since the COVID-19 pandemic began and plethora of research into SARS-CoV-2 has led to development of vaccines and therapeutics. In this article, we review what we’ve known about SARS-CoV-2 and COVID-19, the developments in fighting the pandemic and the threat of emerging variants.
2021/03/01     Read: 9987
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
A summary of SARS-CoV-2 cell entry mechanisms
2021/02/19     Read: 2810
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
ACRO providing PATH, a non-profit global health organization, with materials to support the development of high quality COVID-19 diagnostics
2021/02/17     Read: 1963
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
Neutralizing Antibodies in the Fight against COVID-19
COVID-19 neutralizing antibodies (NAbs) have been one of the big stories of the coronavirus pandemic. Produced by immune system B cells, NAbs stop infections by incapacitating the invading pathogen. From the moment their discovery was announced in May 2020, coronavirus NAbs were touted as possible t
2021/02/16     Read: 1297
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
ACROBiosystems Enables the Development of New Tools to Fight SARS-CoV-2
In December, 2019, a novel coronavirus hit the human population and caused a worldwide pandemic from which we have yet to recover. Even considering that the current vaccines will be successful, we are still in need of more tools and novel approaches to effectively fight back the evolving SARS-CoV-2
2021/02/10     Read: 3007
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
Can aerosolized nanobodies be a gamechanger in the fight against COVID-19?
After the outbreak of SARS-CoV-2, researchers as well as biotech and pharma industry responded quickly to develop vaccines and therapeutics. Within less than a years’ time, breakthroughs in research and developments brought multiple vaccines and antibody therapeutics to hospitals at an unprecedented
2021/01/27     Read: 3845
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
SARS-CoV-2 Infection: Do You Know About the Antibody-Dependent Enhancement (ADE)?
ACROBiosystems has developed a series of products, which can be used for the measurement of the anti-SARS-CoV-2 antibody isotypes like IgG1, IgG2, IgG3, and IgG4.
2020/12/09     Read: 7124
SARS-CoV-2 Related Products SARS-CoV-2 diagnostics
More

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap